Neuropeptide-processing enzymes: Applications for drug discovery

AAPS Journal

Volumn 7, Issue 2, 2005, Pages

  Fricker, Lloyd D ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Carboxypeptidase; Peptide biosynthesis; Peptidomics; Prohormone convertase

Indexed keywords

CARBOXYPEPTIDASE; ENZYME INHIBITOR; NEUROPEPTIDE; PEPTIDASE; PROPROTEIN CONVERTASE 1; PROPROTEIN CONVERTASE 2; PROTEIN PRECURSOR; SIGNAL PEPTIDASE;

ARTICLE; BIOSYNTHESIS; CELL COMMUNICATION; DRUG RESEARCH; DRUG TARGETING; MUTANT; NONHUMAN; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PROCESSING; PROTEIN SECRETION; PROTEIN SYNTHESIS;

ANIMALS; HUMANS; NEUROPEPTIDES; PEPTIDE HYDROLASES; TECHNOLOGY, PHARMACEUTICAL;

EID: 30444432702     PISSN: 15221059     EISSN: 15221059     Source Type: Journal    
DOI: 10.1208/aapsj070244     Document Type: Article

References (73)

1. Clynen E, De Loof A, Schoofs L. The use of peptidomics in endocrine research. Gen Comp Endocrinol. 2003;132:1-9.
2. Strand FL. Neuropeptides: general characteristics and neuropharmaceutical potential in treating CNS disorders. Prog Drug Res. 2003;61:1-37.
3. Tanaka H, Yoshida T, Miyamoto N, et al. Characterization of a family of endogenous neuropeptide ligands for the G protein-coupled receptors GPR7 and GPR8. Proc Natl Acad Sci USA. 2003;100:6251-6256.
4. Docherty K, Steiner DF. Post-translational proteolysis in polypeptide hormone biosynthesis. Annu Rev Physiol, 1982;44:625-638.
5. Lindberg I, Hutton JC. Peptide processing proteinases with selectivity for paired basic residues. In: Fricker LD, ed. Peptide Biosynthesis and Processing. Boca Raton, FL: CRC Press; 1991:141-174.
6. Devi L. Peptide processing at monobasic sites. In: Fricker LD, ed. Peptide Biosynthesis and Processing. Boca Raton, FL: CRC Press; 1991:175-198.
7. Zhou A, Webb G, Zhu X, Steiner DF. Proteolytic processing in the secretory pathway. J Biol Chem. 1999;274:20745-20748.
8. Seidah NG, Prat A. Precursor convertases in the secretory pathway, cytosol and extracellular milieu. Essays Biochem. 2002;38:79-94.
9. fat mice. Proc Natl Acad Sci USA. 2001; 98:9971-9976.
10. Sigafoos J, Chestnut WG, Merrill BM, Taylor LCE, Diliberto EJ, Viveros OH. Novel peptides from adrenomedullary chromaffin vesicles. J Anat. 1993;183:253-264.
11. Vilim FS, Aarnisalo AA, Nieminen M, et al. Gene for pain modulatory neuropeptide NPFF: induction in spinal cord by noxious stimuli. Mol Pharmacol. 1999;55:804-811.
12. fat mice using differential isotopic tags and mass spectrometry. Anal Chem. 2002,74:3190-3198.
13. Che F-Y, Fricker LD. Quantitative peptidomics of mouse pituitary: comparison of different stable isotopic tags. J Mass Spectrom. 2005;40:238-249.
14. Che F-Y, Biswas R, Fricker LD. Relative quantitation of peptides in wild type and Cpefat/fat mouse pituitary using stable isotopic tags and mass spectrometry. J Mass Spectrom. 2005;40:227-237.
15. Pan H, Nanno D, Che FY, et al. Neuropeptide processing profile in mice lacking prohormone Convertase-1. Biochemistry. 2005;44:4939-4948.
16. fat mouse hypothalamus: effect of food deprivation and exercise on peptide levels. J Biol Chem. 2005; 280:4451-4461.
17. Smeekens SP, Steiner DF. Identification of a human insulinoma cDNA encoding a novel mammalian protein structurally related to the yeast dibasic processing protease Kex2. J Biol Chem. 1990;265:2997-3000.
18. Seidah NG, Marcinkiewicz M, Benjannet S, et al. Cloning and primary sequence of a mouse candidate prohormone convertase PC1 homologous to PC2, furin, and Kex2: distinct chromosomal localization and messenger RNA distribution in brain and pituitary compared to PC2. Mol Endocrinol. 1991,5:111-122.
19. Smeekens SP, Avruch AS, LaMendola J, Chan SJ, Steiner DF. Identification of a cDNA encoding a second putative prohormone convertase related to PC2 in AtT-20 cells and islets of Langerhans. Proc Natl Acad Sci USA. 1991;88:340-344.
20. Schafer MKH Day R, Cullinan WE, Chretien M, Seidah NG, Watson SJ. Gene expression of prohormone and proprotein convertases in the rat CNS: a comparative in situ hybridization analysis. J Neurosci. 1993;13:1258-1279.
21. Braks JAM, Martens GJM. 7B2 is a neuroendocrine chaperone that transiently interacts with prohormone convertase PC2 in the secretory pathway. Cell. 1994;78:263-273.
22. Fricker LD, McKinzie AA, Sun J, et al. Identification and characterization of proSAAS, a granin-like neuroendocrine peptide precursor that inhibits prohormone processing. J Neurosci. 2000;20:639-648.
23. Zhu X, Rouille Y, Lamango NS, Steiner DF, Lindberg I. Internal cleavage of the inhibitory 7B2 CT peptide by PC2: a potential mechanism for its inactivation. Proc Natl Acad Sci USA. 1996;93:4919-4924.
24. Cameron A, Fortenberry Y, Lindberg I. The SAAS granin exhibits structural and functional homology to 7B2 and contains a highly potent hexapeptide inhibitor of PC1. FEBS Lett. 2000;473:135-138.
25. Furuta M, Yano II, Zhou A, et al. Defective prohormone processing and altered pancreatic islet morphology in mice lacking active SPC2. Proc Natl Acad Sci USA. 1997;94:6646-6651.
26. Furuta M, Zhou A, Webb G, et al. Severe defect in proglucagon processing in islet A-cells of prohormone convertase 2 null mice. J Biol Chem. 2001;276:27197-27202.
27. Zhu X, Orci L, Carroll R, Norrbom C, Ravazzola M, Steiner DF. Severe block in processing of proinsulin to insulin accompanied by elevation of des-64,65 proinsulin intermediates in islets of mice lacking prohormone convertase 1/3. Proc Natl Acad Sci USA. 2002;99:10299-10304.
28. Zhou A, Bloomquist BT, Mains RE. The prohormone convertases PC1 and PC2 mediate distinct endoproteolytic cleavages in a strict temporal order during proopiomelanocortin biosynthetic processing. J Biol Chem. 1993;268:1763-1769.
29. Breslin MB, Lindberg I, Benjannet S, Mathis JP, Lazure C, Seidah NG. Differential processing of proenkephalin by prohormone convertases 1(3) and 2 and furin. J Biol Chem. 1993;268:27084-27093.
30. Zhou A, Mains RE. Endoproteolytic processing of proopiomelanocortin and prohormone convertases 1 and 2 in neuroendocrine cells overexpressing prohormone convertases 1 or 2. J Biol Chem. 1994;269:17440-17447.
31. Fricker LD, Snyder SH Enkephalin convertase: purification and characterization of a specific enkephalin-synthesizing carboxypeptidase localized to adrenal chromaffin granules. Proc Natl Acad Sci USA. 1982;79:3886-3890.
32. Fricker LD. Carboxypeptidase E. Annu Rev Physiol. 1988;50:309-321.
33. Aloy P, Companys V, Vendrell J, et al. The crystal structure of the inhibitor-complexed carboxypeptidase D domain II as a basis for the modelling of regulatory carboxypeptidases. J Biol Chem. 2001;276:16177-16184.
34. Nalamachu SR, Song L, Fricker LD. Regulation of carboxypeptidase E: effect of Ca2+ on enzyme activity and stability. J Biol Chem. 1994;269:11192-11195.
35. Fricker LD, Snyder SH. Purification and characterization of enkephalin convertase, an enkephalin-synthesizing carboxypeptidase. J Biol Chem. 1983;258:10950-10955.
36. Smyth DG, Maruthainar K, Darby NJ, Fricker LD. C-terminal processing of neuropeptides: involvement of carboxypeptidase H. J Neurochem. 1989;53:489-493.
37. Chen H, Jawahar S, Qian Y, et al. A missense polymorphism in the human carboxypeptidase E gene alters its enzymatic activity: possible implications in type 2 diabetes mellitus. Hum Mutat. 2001;18:120-131.
38. Naggert JK, Fricker LD, Varlamov O, et al. Hyperproinsulinemia in obese fat/fat mice associated with a point mutation in the carboxypeptidase E gene and reduced carboxypeptidase E activity in the pancreatic islets. Nat Genet. 1995;10:135-142.
39. Varlamov O, Leiter EH, Fricker LD. Induced and spontaneous mutations at Ser202 of carboxypeptidase E: effect on enzyme expression, activity, and intracellular routing. J Biol Chem. 1996;271:13981-13986.
40. Fricker LD, Berman YL, Leiter EH, Devi LA. Carboxypeptidase E activity is deficient in mice with the fat mutation: effect on peptide processing. J Biol Chem. 1996;271:30619-30624.
41. Rovere C, Viale A, Nahon J, Kitabgi P. Impaired processing of brain proneurotensin and promelanin-concentrating hormone in obese fat/fat mice. Endocrinology. 1996;137:2954-2958.
42. Udupi V, Gomez P, Song L, et al. Effect of carboxypeptidase E deficiency on progastrin processing and gastrin mRNA expression in mice with the fat mutation. Endocrinology. 1997;138:1959-1963.
43. fat mice: a regional difference in the involvement of carboxypeptidase E (Cpe) in pro-CCK processing. Endocrinologv. 1997;138:4034-4037.
44. Song L, Fricker LD. Purification and characterization of carboxypeptidase D, a novel carboxypeptidase E-like enzyme, from bovine pituitary. J Biol Chem. 1995;270:25007-25013.
45. Varlamov O, Fricker LD. Intracellular trafficking of metallocarboxypeptidase D in AtT-20 cells: localization to the trans-Golgi network and recycling from the cell surface. J Cell Sci. 1998;111:877-885.
46. Varlamov O, Eng FJ, Novikova EG, Fricker LD. Localization of metallocarboxypeptidase D in AtT-20 cells: potential role in prohormone processing. J Biol Chem. 1999;274:14759-14767.
47. Eipper BA, Milgram SL, Husten EJ, Yun HY, Mains RE. Peptidylglycine alpha-amidating monooxygenase: a multifunctional protein with catalytic, processing, and routing domains. Protein Sci. 1993;2:489-497.
48. Ouafik LH, Stoffers DA, Campbell TA, et al. The multifunctional peptidylglycine alpha-amidating monooxygenase gene: exon/intron organization of catalytic, processing, and routing domains. Mol Endocrinol. 1992;6:1571-1584.
49. Prigge ST, Mains RE, Eipper BA, Amzel LM. New insights into copper monooxygenase and peptide amidation: structure, mechanism, and function. Cell Mol Life Sci. 2000;57:1236-1259.
50. Kolhekar AS, Mains RE, Eipper BA. Peptidylglycine alpha-amidating monooxygenase: an ascorbate-requiring enzyme. Meth Enzymol. 1997;279:35-43.
51. Bradbury AF, Smyth DG. Modification of the N- and C-termini of bioactive peptides: amidation and acetylation. In: Fricker LD, ed. Peptide Biosynthesis and Processing Boca Raton, FL: CRC Press; 1991:231-250.
52. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 1999;402:656-660.
53. Lee RWH, Huttner WB. Tyrosine O-sulfated proteins of PC1 pheochromocytoma cells and their sulfation by tyrosylprotein sulfotransferase. J Biol Chem. 1983;258:11326-11332.
54. Bennett HPJ. Glycosylation, phosphorylation, and sulfation of peptide hormones and their precursors. In: Fricker LD, ed. Peptide Biosynthesis and Processing Boca Raton, FL: CRC Press; 1991:111-140.
55. Svensson M, Skold K, Svenningsson P, Andren PE. Peptidomics-based discovery of novel neuropeptides. J Proteome Res. 2003;2:213-219.
56. Turner AJ. Exploring the structure and function of zinc metallopeptidases: old enzymes and new discoveries. Biochem Soc Trans. 2003;31:723-727.
57. Albiston AL, Ye S, Chai SY. Membrane bound members of the M1 family: more than aminopeptidases. Protein Pept Lett. 2004;11:491-500.
58. Kim SI, Grum-Tokars V, Swanson TA, et al. Novel roles of neuropeptide processing enzymes: EC3.4.24.15 in the neurome. J Neurosci Res. 2003;74:456-467.
59. Smith AI, Clarke IJ, Lew RA. Post-secretory processing of peptide signals: a novel mechanism for the regulation of peptide hormone receptors. Biochem Soc Trans. 1997;25:1011-1014.
60. Goumon Y, Lugardon K, Gadroy P, et al. Processing of proenkephalin-A in bovine chromaffin cells. Identification of natural derived fragments by N-terminal sequencing and matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Biol Chem. 2000;275:38355-38362.
61. Wei S, Segura S, Vendrell J, et al. Identification and characterization of three members of the human metallocarboxypeptidase gene family. J Biol Chem. 2002;277:14954-14964.
62. Fontenele-Neto JD, Kalinina E, Feng Y, Fricker LD. Identification and distribution of mouse carboxypeptidase A-6. Brain Res Mol Brain Res.
63. Emoto N, Yanagisawa M. Endothelin-converting enzyme-2 is a membrane-bound, phosphoramidon-sensitive metalloprotease with acidic pH optimum. J Biol Chem. 1995;270:15262-15268.
64. Mzhavia N, Pan H, Che F-Y, Fricker LD, Devi LA. Characterization of endothelin-converting enzyme-2. Implication for a role in the nonclassical processing of regulatory peptides. J Biol Chem. 2003;278:14704-14711.
65. Srinivasan S, Bunch DO, Feng Y, et al. Deficits in reproduction and pro-gonadotropin-releasing hormone processing in male Cpefat mice. Endocrinology. 2004;145:2023-2034.
66. Qian Y, Devi LA, Mzhavia N, Munzer S, Seidah NG, Fricker LD. The C-terminal region of proSAAS is a potent inhibitor of prohormone convertase 1. J Biol Chem. 2000;275:23596-23601.
67. Wei S, Feng Y, Che F-Y, et al. Obesity and diabetes in transgenic mice expressing proSAAS. J Endocrinol. 2004;180:357-368.
68. Sakurai T, Amemiya A, Ishii M, et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G-protein-coupled receptors that regulate feeding behavior. Cell. 1998;92:573-585.
69. Preti A. Orexins (hypocretins): their role in appetite and arousal. Curr Opin Investig Drugs. 2002;3:1199-1206.
70. Rodgers RJ, Ishii Y, Halford JC, Blundell JE. Orexins and appetite regulation. Neuropeptides. 2002;36:303-325.
71. Tao WA, Aebersold R. Advances in quantitative proteomics via stable isotope tagging and mass spectrometry. Curr Opin Biotechnol. 2003;14:110-118.
72. Goshe MB, Smith RD. Stable isotope-coded proteomic mass spectrometry. Curr Opin Biotechnol. 2003;14:101-109.
73. Che F-Y, Eipper BA, Mains RE, Fricker LD. Quantitative peptidomics of pituitary glands from mice deficient in copper transport. Cell Mol Biol. 2003;49:713-722.